What is Hester Biosciences Ltd (HESTERBIO) share price return in the past 10 years?

Hester Biosciences Ltd share price has appreciated 11.9% annually (CAGR) over the past ten years.

What is the share price of Hester Biosciences Ltd (HESTERBIO)?

Company share prices are keep on changing according to the market conditions. The current trading price of Hester Biosciences Ltd (HESTERBIO) on 04-Jun-2026 16:59:59 at 16:59 is 1919.70.

What is the P/E ratio of Hester Biosciences?

The latest standalone P/E ratio of Hester Biosciences as of 04-Jun-2026 is 31.34.

What is the P/B ratio of Hester Biosciences Ltd (HESTERBIO)?

The latest standalone P/B ratio of Hester Biosciences Ltd (HESTERBIO) as of 04-Jun-2026 is 4.24.

What is the 52-week high and low of Hester Biosciences Ltd (HESTERBIO)?

The 52-week high of Hester Biosciences Ltd (HESTERBIO) is Rs. 2347.70 and the 52-week low is Rs. 1250.95.

Hester Biosciences Ltd (HESTERBIO) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Hester Biosciences Ltd (HESTERBIO)
Brand: Hester Biosciences

Hester Biosciences Ltd (HESTERBIO)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524669 NSE: HESTERBIO Pharmaceuticals & Drugs | Small Cap | Hester Biosciences Share Price

Hester Biosciences Ltd (HESTERBIO)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524669 NSE: HESTERBIO Pharmaceuticals & Drugs | Small Cap | Hester Biosciences Share Price

Key Metrics

Valuation Multiples

Market Cap

₹1,633 Cr.

Current Price

₹1,919.7

52-Week Low / High

₹1,251 / 2,348

TTM EPS

₹61.2

TTM Sales

₹292 Cr.

Book Value per Share

₹452.8

P/E Ratio

31.34

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

4.24

Lower than its 5-year historical median

Price to Sales (P/S)

5.59

Lower than its 5-year historical median

EV/EBITDA

21.26

Lower than its 5-year historical median

Dividend Yield

0.56%

Profitability Efficiency

Return on Equity (ROE)

9.77%

Outperforms industry median

Return on Capital Employed (ROCE)

10.59%

Underperforms industry median

Return on Assets (ROA)

5.81%

Operating Profit Margin

18%

Net Profit Margin

11.12%

Gross Profit Margin

17.6%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

0.46%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

8.73%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

17.23%

Asset Quality

Promoter Holding

53.73%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹377 Cr.

Equity

₹8.5 Cr.

Face Value

₹10

All Time Low / High

₹0.25 / 3375.45

Hester Biosciences stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Hester Biosciences Ltd a good quality company?

Hester Biosciences Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Hester Biosciences Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Hester Biosciences Ltd vs industry peers?

Hester Biosciences Ltd revenue CAGR is 11.08%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Hester Biosciences Ltd?

Promoters hold 53.73% of the Hester Biosciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Hester Biosciences Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 11.4% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	21.8%	24.2%	26.3%	31.2%	19.7%	23.3%	17.3%	11.9%	9.3%	10.6%	-
Value Creation Index ⓘ	0.6	0.7	0.9	1.2	0.4	0.7	0.2	-0.2	-0.3	-0.2	-
Growth Parameters ⓘ
Sales ⓘ	101	123	135	171	169	208	219	254	285	286	292
Sales YoY Gr.	-	22.2%	9.3%	27%	-1%	23.1%	5.2%	15.8%	12.3%	0.5%	-
Adj EPS ⓘ	22.8	29.3	35.8	50.9	35.7	51.6	45.4	36.9	31.5	37.1	61.2
YoY Gr.	-	28.7%	22%	42.4%	-29.8%	44.3%	-11.9%	-18.7%	-14.6%	17.6%	-
BVPS (₹) ⓘ	117.9	143.5	171.7	210.9	238.7	279.3	315.5	343.7	367.6	398.6	452.8
Adj Net Profit ⓘ	19.4	24.9	30.4	43.3	30.4	43.9	38.6	31.4	26.8	31.6	52
Cash Flow from Ops. ⓘ	18.6	27.6	32.3	36.2	25.8	41.1	15.9	33.4	42.9	64	-
Debt/CF from Ops. ⓘ	2.1	1.4	1.3	1.1	1.9	0.4	7.7	4.9	3.1	1.6	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	12.3%	11.1%	9.3%	0.5%
Adj EPS ⓘ	5.6%	0.8%	-6.5%	17.6%
BVPSⓘ	14.5%	10.8%	8.1%	8.4%
Share Price	11.9%	-6.4%	5.4%	2.6%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	21	22.4	22.7	26.6	15.9	19.9	15.3	11.2	8.9	9.7	14.4
Op. Profit Mgn % ⓘ	33.4	33.4	36.8	39.7	31.1	34.7	27.6	21.5	16.4	18	24.8
Net Profit Mgn % ⓘ	19.2	20.2	22.6	25.3	18	21	17.6	12.4	9.4	11	17.8
Debt to Equity ⓘ	0.4	0.3	0.3	0.2	0.2	0.1	0.5	0.6	0.4	0.3	0.1
Working Cap Days ⓘ	229	217	220	208	261	245	279	292	271	252	108
Cash Conv. Cycle ⓘ	160	140	140	134	164	145	164	168	152	131	53

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	101	123	135	171	169	208	219	254	285	286
Operating Expenses ⓘ +	67	82	85	103	117	136	159	199	238	236
Manufacturing Costs	14	12	15	18	19	18	19	20	28	26
Material Costs	20	30	23	29	29	53	64	80	100	94
Employee Cost	15	18	22	27	37	33	39	48	57	55
Other Costs ⓘ	19	22	25	29	32	32	37	51	54	61
Operating Profit ⓘ	33	41	50	68	53	72	61	55	47	51
Operating Profit Margin (%)	33.1%	33.3%	36.8%	39.6%	31.1%	34.5%	27.6%	21.5%	16.4%	17.8%
Other Income ⓘ +	1	1	2	3	3	2	5	6	5	5
Exceptional Items ⓘ	0	0	0	0	0	-5	0	0	0	0
Interest ⓘ	4	3	2	4	5	4	2	6	5	5
Depreciation ⓘ	6	6	5	8	9	10	10	10	10	9
Profit Before Tax ⓘ	25	33	44	60	41	55	53	44	37	42
Tax ⓘ	6	8	13	16	10	15	14	12	10	10
Profit After Tax	19	25	31	44	31	40	40	32	27	32
PAT Margin (%)	19.1%	20.2%	22.7%	25.6%	18.4%	19.1%	18.0%	12.7%	9.5%	11.1%
Adjusted EPS (₹)	22.6	29.3	35.9	51.6	36.7	46.9	46.5	38.0	31.9	37.4
Dividend Payout Ratio (%)	18.10%	18.10%	27.80%	21.30%	18%	21.30%	21.50%	21%	18.80%	18.70%

Valuation of Hester Biosciences - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	100	122	146	179	203	238	268	292	313	339
Share Capital ⓘ	9	9	9	9	9	9	9	9	9	9
Reserves ⓘ	92	114	138	171	195	229	260	284	304	331
Debt +	34	36	39	32	39	4	107	141	109	80
Long Term Debt	13	19	15	11	7	3	73	83	79	51
Short Term Debt	21	18	24	21	32	2	33	57	30	29
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	7	8	8	14	14	11	29	30	33
Others Liabilities ⓘ	19	13	18	20	21	26	38	84	98	94
Total Liabilities ⓘ	159	178	210	240	277	282	424	546	550	546
Fixed Assets
Net Fixed Assets ⓘ +	62	61	67	101	97	87	84	108	103	105
Gross Block	105	110	121	162	167	165	171	199	204	212
Accumulated Depreciation	43	49	54	61	70	78	87	91	100	107
CWIP ⓘ	10	21	30	0	1	4	82	149	171	183
Investments ⓘ	9	9	14	28	41	44	65	65	65	65
Inventories	34	33	39	48	60	57	71	79	69	59
Trade Receivables	26	27	32	33	45	46	57	82	86	81
Cash Equivalents	5	11	12	2	5	1	2	6	5	2
Others Assets ⓘ	13	16	16	27	28	44	64	57	51	52
Total Assets ⓘ	159	178	210	240	277	282	424	546	550	546

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	19	28	32	36	26	41	16	33	43	64
PBT ⓘ	25	33	44	60	41	55	53	44	37	42
Adjustment ⓘ	9	9	7	8	12	20	12	15	13	16
Changes in Working Capital ⓘ	-10	-7	-9	-16	-16	-20	-33	-17	4	16
Tax Paid ⓘ	-6	-7	-9	-16	-11	-13	-16	-8	-11	-10
Cash Flow From Investing Activity ⓘ +	-6	-15	-26	-25	-21	-4	-111	-72	-21	-19
Capex	-6	0	-21	-12	-7	-4	-90	-73	-22	-20
Net Investments	0	0	-0	-1	-2	1	-20	0	0	0
Others ⓘ	0	-16	-5	-12	-12	-1	0	0	2	1
Cash Flow From Financing Activity ⓘ +	-12	-6	-6	-20	-1	-41	95	41	-24	-46
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-2	6	-4	-3	-1	-2	73	12	-3	-28
Interest Paid ⓘ	-4	-3	-2	-4	-4	-4	-1	-10	-13	-13
Dividend Paid ⓘ	-5	-4	-6	-10	-7	-6	-9	-9	-7	-5
Others ⓘ	-1	-4	7	-3	11	-30	32	48	-2	-1
Net Cash Flow ⓘ	1	6	-0	-9	3	-4	0	3	-2	-1

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	20.83	22.43	22.79	26.94	16.33	18.11	15.62	11.53	8.98	9.77
ROCE (%)	21.79	24.16	26.28	31.15	19.74	23.28	17.31	11.91	9.26	10.59
Asset Turnover Ratio	0.69	0.74	0.7	0.76	0.65	0.75	0.63	0.53	0.52	0.52
PAT to CFO Conversion(x)	1	1.12	1.03	0.82	0.84	1.03	0.4	1.03	1.59	2
Working Capital Days
Receivable Days	78	77	79.10	68.90	83.40	79.10	84.50	99.30	107.50	105.90
Inventory Days	111.10	96.90	96.80	93	117.30	102.80	105.40	106.90	94.50	80.90
Payable Days	96.70	81.30	120	99.30	135.20	94.40	71.60	90.80	107	121.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hester Biosciences Ltd FAQs

The current trading price of Hester Biosciences on 04-Jun-2026 16:59 is ₹1,919.7.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Hester Biosciences stood at ₹1,633.1 Cr

The latest P/E ratio of Hester Biosciences as of 03-Jun-2026 is 31.34.

The latest P/B ratio of Hester Biosciences as of 03-Jun-2026 is 4.24.

The 52-week high of Hester Biosciences is ₹2,347.7 and the 52-week low is ₹1,251.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hester Biosciences is ₹292 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hester Biosciences Ltd is a good quality company.

The key valuation ratios of Hester Biosciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Hester Biosciences Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Hester Biosciences Ltd

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes â€“ A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

Live Vaccines
Killed Vaccines
Diagnostic kits & Seromonitoring services

Achievements/ recognition:

GMP and ISO 9001:2000 certified company

Hester Biosciences Ltd (HESTERBIO)

Hester Biosciences Ltd (HESTERBIO)

Hester Biosciences stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hester Biosciences - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hester Biosciences Ltd FAQs

About Hester Biosciences Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Hester Biosciences Ltd (HESTERBIO)

Hester Biosciences Ltd (HESTERBIO)

Hester Biosciences stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Hester Biosciences - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hester Biosciences Ltd FAQs

What is the share price of Hester Biosciences?

What is the market cap of Hester Biosciences?

What is the P/E ratio of Hester Biosciences?

What is the P/B ratio of Hester Biosciences?

What is the 52-week high and low of Hester Biosciences?

What is the TTM revenue of Hester Biosciences?

Is Hester Biosciences Ltd a good quality company?

Is Hester Biosciences Ltd undervalued or overvalued?

Is Hester Biosciences Ltd a good buy now?

About Hester Biosciences Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.